The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XII.g

Coronary artery disease (acute) - Myocardial ischemia/infarction

Publications

Renard D, Cornillet L, Castelnovo G

Myocardial infarction after rituximab infusion.

Neuromuscular disorders : NMD. 2013;23(7):599-601

van Sijl AM, van der Weele W, Nurmohamed MT

Myocardial infarction after rituximab treatment for rheumatoid arthritis: Is there a link?

Current pharmaceutical design. 2014;20(4):496-9

Arunprasath P, Gobu P, Dubashi B, Satheesh S, Balachander J

Rituximab induced myocardial infarction: A fatal drug reaction.

Journal of cancer research and therapeutics. 2011;7(3):346-8